InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.27
(
0.41%
)
Bitcoin
57,900.12
(
-3.75%
)
Post# of 2342520
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

PRAYFORME

Send PM Follow Ignore
Followers 87
Posts 4359
Boards Moderated 2
Alias Born 05/04/2016

PRAYFORME

Re: None

Friday, 10/21/2016 12:48:25 PM

Friday, October 21, 2016 12:48:25 PM

Post# of 2342520
OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that it has completed the development of a proprietary, cannabinoid-enriched sublingual tablet (the "Tablet") for the administration of medical cannabis.

(Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )

(Photo: http://photos.prnewswire.com/prnh/20161020/430820 )
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up